Omar Fares

🔬 التنقل في تقاطع الذكاء الاصطناعي وطول العمر 🧪

[ASPC @ASPCardio]

🫀 New episode just dropped.

Guidelines are great. But how do you actually build a prevention program that works in the real world?

In our latest episode, Dr. Keerthana Pakanati (@Kpakanati3) sits down with Dr. Neha Pagidipati (Duke University) and Misha Nazrollahzadeh (Joyce Health) to get practical — team structures, scalable care models, where AI and remote monitoring are actually moving the needle (and where the hype is getting ahead of the evidence), and what it looks like to make nutrition care work in the GLP-1 era.

Whether you're trying to launch a prevention clinic or strengthen the one you have — this one's for you.

🎧 https://t.co/plRR4Y5OGu

#HeartOfPrevention #PreventiveCardiology #CardiovascularHealth #PreventionClinic #HealthcareLeadership #CardioTwitter #MedEd #HeartHealth #GLP1 #ImplementationScience @AJPCardio

[Science Magazine @ScienceMagazine]

Successful mitosis may draw on more mechanisms than commonly assumed, according to Science research from last year.

Learn more: https://t.co/LCgDyM1ilc #ScienceMagArchives

[Ahmed Bennis MD 🫀 @drbennisahmed]

Big new UK Biobank study (89,537 people, wrist accelerometers, 761 diseases tracked): sedentary time is linked to higher risk of 75 diseases — cardiovascular-kidney-metabolic conditions top the list.

https://t.co/VJD3YkRMsT

[European Society of Cardiology @escardio]

#WednesdayRead: Statins and survival free of incident frailty among older US veterans

Beyond LDL: could statins help protect against frailty?
Frailty and cardiovascular disease share inflammatory pathways, yet no drug strategy is established to prevent frailty. In this large retrospective study of 987,301 statin-naïve, non-frail US veterans aged ≥67 years, new statin initiation was associated with a lower risk of incident frailty over 5.3 years after propensity weighting (HR 0.76, 95% CI 0.75–0.76), with similar findings in pre-frail veterans. These data may prompt cardiologists to view statins not only as lipid-lowering therapy, but also as a potential tool to support healthy ageing https://t.co/7eB9qKPvSu

#EHJ

[Future Health – A Global Initiative by Abu Dhabi @FutureHealthAD]

What if the first sign of disease wasn't a symptom, but a signal?​

Today, most diagnoses begin after symptoms appear, when conditions are already progressing. But advances in genomics, wearable technologies, and real-time data are enabling detection closer to the source, identifying risk before disease becomes visible. ​

When integrated across health systems, these sensors and data streams work together: wearables detecting physiological shifts, genomics flagging population-level risk, and data systems connecting the signals into a coherent, actionable picture.​

This is the shift from treatment to prevention where earlier detection, driven by system-level integration of sensing and data, means intervention happens sooner, outcomes improve, and health is protected before it is lost.​

#FutureHealthAD #ToSenseIsToPredict #PrecisionMedicine

[EASD @EASDnews]

🧠Meet Dr. Ben A. Kappel recipient of the #EFSD & @Sanofi European Diabetes Research Programme in #CVD. 👏
He investigates how #T2D alters cardiac #metabolism & contributes to heart failure with preserved ejection fraction (HFpEF).
📄 Under preparation
💡 https://t.co/Q5EOaFNmin

[Otavio Berwanger @OtavioBerwanger]

Underrated but very relevant mechanism related to obesity

[Seamus O’Reilly MD PhD @Seamusoreilly18]

“Succession is an integral part of Successful Research”
Very honoured to have co led with @nlinmd this dynamic global group of early #breastcancer investigators & learn how we can support them 👇
🙏 to co- ✍️ & @BCRFcure for funding

[Science Magazine @ScienceMagazine]

A decline in the availability of oxidized nicotinamide adenine dinucleotide (NAD+) is an important trigger of aging across diverse species, including yeast, nematodes, and mammals. Decreased concentrations of this metabolic molecule drive progressive losses of physiological function across various tissues.

In a new Science study, researchers report that NAD+ depletion in the placenta is not merely a marker of tissue fatigue. Rather, NAD+ decline is a regulatory component of a precisely orchestrated metabolic countdown that determines when a new life is brought into existence.

More generally, this discovery reframes the role of NAD+ in metabolism, development, and aging.

Learn more in a new #SciencePerspective: https://t.co/9li3e4MwlS

[Insilico Medicine @InSilicoMeds]

https://t.co/qH0b7HwmYw

What happens when one of the world’s ultimate pioneers in artificial intelligence steps into a fully automated, robotic drug discovery lab?

Insilico Medicine CEO, Alex Zhavoronkov had the absolute privilege of hosting Dr. Kai-Fu Lee at our Shanghai facilities for an exclusive, deep-dive conversation.

This kickoff marks the start of an exciting new series where we bridge the gap between pure tech and biological breakthroughs. We didn't just talk about code; we talked about the tangible future of human health.

If you want to know where the next decade of deep tech is going, you won’t want to miss this series.

Stay tuned for more in our series: Bits to Bio with Alex Zhavoronkov & Dr. Kai-Fu Lee! 🎬

What do you think will be AI's most disruptive contribution to healthcare over the next 5 years? Let’s discuss in the comments. 👇

#ArtificialIntelligence #Biotech #GenerativeAI #DrugDiscovery #DeepTech #Innovation #Healthcare

[EASO @EASOobesity]

📣 EASO COMs members: Do you have a case study or clinical insight to share for the EASO COMs Summit 2026 in Potsdam 🇩🇪

Learn more and submit your abstract by 24 July https://t.co/544NcuOUPQ

✈️ Travel grants are available by application for eligible @EASOobesityECN members.

[JAHA @JAHA_AHA]

In a large, retrospective, contemporary HFrEF cohort initiated on GDMT, NT-proBNP offered much greater prognostic value than LVEF. @WilsonTangMD https://t.co/wHwvOlE73h

[Review of Optometry @revoptom]

Study: Polygenic Risk Score for Glaucoma Impacts Prognosis

Such tools must be combined with typical clinical assessments, but they can help doctors estimate the lifetime likelihood of Dx and identify those at risk of earlier onset or more severe disease.
https://t.co/UksW2CMkGm

[The Lancet @TheLancet]

Presented at #EHA2026 ⤵️

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial https://t.co/dN4K4LNhO4 @EHA_Hematology

[The BMJ @bmj_latest]

State of the Art Review: Advances in the development of malaria vaccines

This review explores recent advances and future directions in malaria vaccine development #MedEd
https://t.co/kSua52pTLq

[Rong Fan @RongFan8]

Delighted to share our latest review on 3D multi-omics tumor atlases. A major @theNCI #HTAN team work w/ @deniswirtz @AshleyKiemen @StimulatedRaman @SStevenWang, kudos to my phenomenal postdoc @Miao__Liu and co-contributors Jorge, Andre, & Xiaolong, on this team work! 🥰

[evo-devo @Xiaojie_Qiu]

Introducing PantheonOS Live View

PantheonOS agents can now open popular interactive scientific viewers, including 3D Spatial Viewer with WebGL, Viv (spatial imaging), Vitessce (single cell & spatial omics), IGV (genomics browser), and Mol* (3D molecular structures), directly on your data, explore data interactively with your agent, and generate publication-grade figures, all live in your browser.
This transforms the agent experience from static reports into an interactive, visual workflow where you can inspect data, explore results, and follow analyses as they happen.

Alongside Live View, the PantheonOS online platform has received a major upgrade, delivering substantially improved stability and reliability for long-horizon analyses, together with more than 4× faster execution speeds than previous releases.

[Samuel Hume @DrSamuelBHume]

Source: https://t.co/8wAd1p7cmZ

[Samuel Hume @DrSamuelBHume]

Has the use of low-dose aspirin for primary cardiovascular prevention reduced since the 2018 trio of trials showed small/absent benefit, but increased bleeding risk?

In some cool work from Epic Research, yes it has:

[GHIT Fund (グローバルヘルス技術振興基金) @GHITFund]

June 15 is World Dengue Day. With approximately 50% of the world's population at risk of infection, dengue fever is a serious public health issue and is designated as one of the Neglected Tropical Diseases (#NTDs)

Due to global warming, mosquitoes are expanding their territory, meaning dengue is no longer just a tropical disease.

What can we do today? Let’s raise awareness together. I hope today serves as an opportunity for everyone to learn more about dengue fever! 🦟

Act Now—End Neglect.
#WorldDengueDay #WDD #dengue